Mainz Biomed N.V. (MYNZ) Fundamentals

Mainz Biomed BV is engaged in developing molecular genetic diagnostic solutions for life-threatening conditions. It's main product Coloalert is a kit that includes a stool collector and shipping instructions to return the kit through regular mail to their local lab for testing and results.
SHARE INFORMATION
Market Cap$ 98,552,216
Shares Outstanding14,492,973
Float12,400,111
Percent Float85.56%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 577,348
Latest Fiscal EPS$ -1.62
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions1
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months-
Institutional Holdings Percent0.0%
Institutional Sold Previous 3 Months-
Insider Holdings Date-
Insider Bought Previous 3 Months-
Insider Holdings Percent0.0
Insider Sold Previous 3 Months-
Insider Shares Owned-
TRADING INFO
52 Week High$ 18.63
52 Week Low$ 6.06
52 Week High Change$ -51.64
21 Day Moving Average$ 6.7914
21 Day Extended Moving Average$ 6.8868
50 Day Moving Average$ 7.4418
50 Day Extended Moving Average$ 7.1822
200 Day Moving Average$ 8.9389
200 Day Extended Moving Average$ 8.7071
10 Day Average Volume10,579
20 Day Average Volume11,391
30 Day Average Volume10,964
50 Day Average Volume15,032
Alpha-0.005969
Beta0.9854
Standard Deviation0.194502
R20.111710
7 Day Price Change$ -0.20
7 Day Percent Change-2.86%
21 Day Price Change$ -0.17
21 Day Percent Change-2.44%
30 Day Price Change$ -0.30
30 Day Percent Change-4.23%
Month to Date Price Change$ 0.20
Month to Date Percent Change3.03%
Quarter to Date Price Change$ -0.30
Quarter to Date Percent Change-4.23%
180 Day Price Change$ -2.76
180 Day Percent Change-28.87%
200 Day Price Change$ -2.60
200 Day Percent Change-27.66%
Year to Date Price Change$ -0.30
Year to Date Percent Change-4.23%

Mainz Biomed N.V. (MYNZ) Key Ratios

PROFITABILITY
EBIT Margin-5,939.8%
EBITDA Margin-5,915.4%
Pre-Tax Profit Margin0.0%
Profit Margin Count-62.72%
Gross Margin-13.5%
Profit Margin TOT-62.72%
INCOME STATEMENTS
Revenue$ 239,805
Revenue Per Share$ 0.0165
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.10
Total Debt To Equity0.10
Int Coverage-83.00
Current Ratio10.80
Leverage Ratio1.20
Quick Ratio10.60
Long Term Debt To Capital0.05
VALUATION MEASURES
PE Ratio-2.70
Enterprise Value$ 73,729,706
Price to Sales410.9682
Price to Free Cash-14.50
PE High Last 5 Years0.00
Price To Book4.10
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book4.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover1.10
Invoice Turnover21.90
Assets Turnover0.00
Return Assets-170.04
Return on Equity-222.09
Return on Capital-178.86

Mainz Biomed N.V. (MYNZ) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorB F Borgers CPA PC
CEOGuido Baechler
Emplyoees31
Last AuditUQ
CIK0001874252
IndustryMedical Diagnostics & Research
SectorHealthcare
NAICS-
CONTACT INFO
AddressRobert-Koch-Strasse 50
Sirius Gutenberg Park
Mainz, 55129
Websitehttps://www.mainzbiomed.com
Facsimile-
Telephone+49 61315542860
Email-
Your Recent History
NASDAQ
MYNZ
Mainz BioM..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20230206 00:18:19